{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:04:17Z","timestamp":1790805857177,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005064","name":"Hebei Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["zh2018001"],"award-info":[{"award-number":["zh2018001"]}],"id":[{"id":"10.13039\/501100005064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Nonalcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver diseases worldwide. Triglyceride (TG) accumulation is central to NAFLD development. People now spend most of their day in the postprandial state, and the measurement of postprandial blood lipid concentration can make up for the lack of simple detection of fasting blood lipids. Postprandial triglyceride (PTG) is commonly used as a surrogate for postprandial blood lipid concentrations, and many studies have shown that PTG is a risk factor for NAFLD. The aim of the present study was to investigate the relationship between PTG concentration during oral fat tolerance testing (OFTT) and NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 472 Chinese adults, aged 25 to 65\u2009years, were enrolled in the study. All the participants underwent OFTT. The serum concentrations of TG and other lipids were measured, and their relationships with NAFLD were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 472 participants, 155 were diagnosed with NAFLD. The fasting and postprandial TG concentrations of the participants with NAFLD were higher than those of healthy participants (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The TG concentrations of the healthy participants peaked 4\u2009h postprandially, whereas those of the participants with NAFLD peaked 6\u2009h postprandially and reached higher peak values. Postprandial TG concentration was significantly associated with a higher risk of NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High PTG is positively related to a higher risk of NAFLD, and the PTG concentrations of patients with NAFLD are higher than in healthy individuals, with a delayed peak. Therefore, 4-h PTG may represent a potential marker of NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/index.aspx\">ChiCTR1800019514<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12944-021-01483-z","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T15:31:35Z","timestamp":1621956695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test"],"prefix":"10.1186","volume":"20","author":[{"given":"Xiaoyu","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9901-6074","authenticated-orcid":false,"given":"Guangyao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,25]]},"reference":[{"issue":"8","key":"1483_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65(8):1017\u201325. https:\/\/doi.org\/10.1016\/j.metabol.2016.01.012.","journal-title":"Metabolism"},{"issue":"1","key":"1483_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incid ence, and outcomes. Hepatology. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"11","key":"1483_CR3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","volume":"113","author":"M Noureddin","year":"2018","unstructured":"Noureddin M, Vipani A, Bresee C, Todo T, Kim IK, Alkhouri N, et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol. 2018;113(11):1649\u201359. https:\/\/doi.org\/10.1038\/s41395-018-0088-6.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1483_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jhep.2017.10.006","volume":"68","author":"R Younes","year":"2018","unstructured":"Younes R, Bugianesi E. Should we undertake surveillance for HCC in patients with NAFLD? J Hepatol. 2018;68(2):326\u201334. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.006.","journal-title":"J Hepatol"},{"issue":"7","key":"1483_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/apt.14937","volume":"48","author":"JG Stine","year":"2018","unstructured":"Stine JG, Wentworth BJ, Zimmet A, Rinella ME, Loomba R, Caldwell SH, et al. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatit is without cirrhosis compared to other liver diseases. Aliment Pharmacol Ther. 2018;48(7):696\u2013703. https:\/\/doi.org\/10.1111\/apt.14937.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"1483_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012.","journal-title":"Metabolism"},{"key":"1483_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2147\/IJGM.S160555","volume":"11","author":"M Alshamiri","year":"2018","unstructured":"Alshamiri M, Ghanaim MMA, Barter P, Chang KC, Li JJ, Matawaran BJ, et al. Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East. Int J Gen Med. 2018;11:313\u201322. https:\/\/doi.org\/10.2147\/IJGM.S160555.","journal-title":"Int J Gen Med"},{"issue":"1","key":"1483_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","volume":"232","author":"P Loria","year":"2014","unstructured":"Loria P, Marchesini G, Nascimbeni F, Ballestri S, Maurantonio M, Carubbi F, et al. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-c irrhotic liver disease due to varying etiology. Atherosclerosis. 2014;232(1):99\u2013109. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.10.030.","journal-title":"Atherosclerosis"},{"issue":"3","key":"1483_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1590-8658(02)80194-3","volume":"34","author":"A Lonardo","year":"2002","unstructured":"Lonardo A, Loria P, Leonardi F, Borsatti A, Neri P, Pulvirenti M, et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis. 2002;34(3):204\u201311. https:\/\/doi.org\/10.1016\/S1590-8658(02)80194-3.","journal-title":"Dig Liver Dis"},{"issue":"12","key":"1483_CR10","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/j.1440-1746.2006.04698.x","volume":"22","author":"PJ Hsiao","year":"2007","unstructured":"Hsiao PJ, Kuo KK, Shin SJ, Yang YH, Lin WY, Yang JF, et al. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol. 2007;22(12):2118\u201323. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04698.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"1483_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13104-020-05059-5","volume":"13","author":"H Tutunchi","year":"2020","unstructured":"Tutunchi H, Saghafi-Asl M, Asghari-Jafarabadi M, Ostadrahimi A. The relationship between severity of liver steatosis and metabolic parameters in a sample of Iranian adults. BMC Res Notes. 2020;13(1):218. https:\/\/doi.org\/10.1186\/s13104-020-05059-5.","journal-title":"BMC Res Notes"},{"key":"1483_CR12","doi-asserted-by":"publisher","first-page":"e1901035","DOI":"10.1002\/mnfr.201901035","volume":"64","author":"YB Sch\u00f6nknecht","year":"2020","unstructured":"Sch\u00f6nknecht YB, Crommen S, Stoffel-Wagner B, Coenen M, Fimmers R, Holst JJ, et al. Acute effects of three different meal patterns on postprandial metabolism in older individuals with a risk phenotype for Cardiometabolic diseases: a randomized controlled crossover trial. Mol Nutr Food Res. 2020;64:e1901035.","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"1483_CR13","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1039\/C9FO02438G","volume":"11","author":"KS Petersen","year":"2020","unstructured":"Petersen KS, Rogers CJ, West SG, Proctor DN, Kris-Etherton PM. The effect of culinary doses of spices in a high-saturated fat, high-carbohydrate meal on postprandia l lipemia and endothelial function: a randomized, controlled, crossover pilot trial. Food Funct. 2020;11(4):3191\u2013200. https:\/\/doi.org\/10.1039\/C9FO02438G.","journal-title":"Food Funct"},{"key":"1483_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovasc ular risk. Eur Heart J. 2020;41:111\u201388.","journal-title":"Eur Heart J"},{"key":"1483_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255\u2013323.","journal-title":"Eur Heart J"},{"issue":"25","key":"1483_CR16","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from th e European atherosclerosis society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944\u201358. https:\/\/doi.org\/10.1093\/eurheartj\/ehw152.","journal-title":"Eur Heart J"},{"key":"1483_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/1570161117999190517115432","volume":"17","author":"GD Kolovou","year":"2019","unstructured":"Kolovou GD, Watts GF, Mikhailidis DP, Mora S, Bilianou H, Panotopoulos G, et al. Postprandial Hypertriglyceridaemia revisited in the era of non-fasting lipid profiles: executive summary of a 2019 expert panel statement. Curr Vasc Pharmacol. 2019;17:538\u201340.","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"1483_CR18","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1210\/jcem.86.10.7952","volume":"86","author":"MJ Quon","year":"2001","unstructured":"Quon MJ. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab. 2001;86(10):4615\u20137. https:\/\/doi.org\/10.1210\/jcem.86.10.7952.","journal-title":"J Clin Endocrinol Metab"},{"key":"1483_CR19","first-page":"195","volume":"26","author":"National Workshop on Fatty L, Alcoholic Liver Disease CSoHCMA, Fatty Liver Expert Committee CMDA","year":"2018","unstructured":"National Workshop on Fatty L, Alcoholic Liver Disease CSoHCMA, Fatty Liver Expert Committee CMDA. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2018;26:195\u2013203.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"2","key":"1483_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"V Ratziu","year":"2010","unstructured":"Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53(2):372\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2010.04.008.","journal-title":"J Hepatol"},{"key":"1483_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cca.2019.01.004","volume":"490","author":"F Tian","year":"2019","unstructured":"Tian F, Xiang QY, Zhang MY, Chen YQ, Lin QZ, Wen T, et al. Changes in non-fasting concentrations of blood lipids after a daily Chinese breakfast in overweight s ubjects without fasting hypertriglyceridemia. Clin Chim Acta. 2019;490:147\u201353. https:\/\/doi.org\/10.1016\/j.cca.2019.01.004.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1483_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/157016111795495530","volume":"9","author":"C Mihas","year":"2011","unstructured":"Mihas C, Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol. 2011;9(3):271\u201380. https:\/\/doi.org\/10.2174\/157016111795495530.","journal-title":"Curr Vasc Pharmacol"},{"issue":"4","key":"1483_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2174\/1570161115666170529084621","volume":"16","author":"P Gavra","year":"2018","unstructured":"Gavra P, Melidonis A, Iraklianou S, Mihas C, Kolovou V, Mavrogeni S, et al. Alterations in plasma triglyceride concentrations following two Oral meals with different fat content in patients with type 2 diabetes mellitus. Curr Vasc Pharmacol. 2018;16(4):385\u201392. https:\/\/doi.org\/10.2174\/1570161115666170529084621.","journal-title":"Curr Vasc Pharmacol"},{"issue":"8","key":"1483_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11745-017-4275-9","volume":"52","author":"N Tentolouris","year":"2017","unstructured":"Tentolouris N, Kanellos PT, Siami E, Athanasopoulou E, Chaviaras N, Kolovou G, et al. Assessment of the validity and reproducibility of a novel standardized test meal for the study of Pos tprandial triacylglycerol concentrations. Lipids. 2017;52(8):675\u201386. https:\/\/doi.org\/10.1007\/s11745-017-4275-9.","journal-title":"Lipids"},{"issue":"5","key":"1483_CR25","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jacl.2016.05.009","volume":"10","author":"P Perez-Martinez","year":"2016","unstructured":"Perez-Martinez P, Alcala-Diaz JF, Kabagambe EK, Garcia-Rios A, Tsai MY, Delgado-Lista J, et al. Assessment of postprandial triglycerides in clinical practice: validation in a general population and coronary heart disease patients. J Clin Lipidol. 2016;10(5):1163\u201371. https:\/\/doi.org\/10.1016\/j.jacl.2016.05.009.","journal-title":"J Clin Lipidol"},{"issue":"3","key":"1483_CR26","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.dsx.2019.04.027","volume":"13","author":"TJE Tarigan","year":"2019","unstructured":"Tarigan TJE, Khumaedi AI, Wafa S, Johan M, Abdullah M, Surono IS, et al. Determinant of postprandial triglyceride levels in healthy young adults. Diabetes Metab Syndr. 2019;13(3):1917\u201321. https:\/\/doi.org\/10.1016\/j.dsx.2019.04.027.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"1483_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12944-018-0803-8","volume":"17","author":"MDR Sevilla-Gonz\u00e1lez","year":"2018","unstructured":"Sevilla-Gonz\u00e1lez MDR, Aguilar-Salinas CA, Mu\u00f1\u00f3z-Hern\u00e1ndez L, Almeda-Vald\u00e9s P, Mehta R, Zubir\u00e1n R, et al. Identification of a threshold to discriminate fasting hypertriglyceridemia with postprandial values. Lipids Health Dis. 2018;17(1):156. https:\/\/doi.org\/10.1186\/s12944-018-0803-8.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"1483_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.aohep.2020.03.001","volume":"19","author":"A Lonardo","year":"2020","unstructured":"Lonardo A, Mantovani A, Lugari S, Targher G. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabo lically unhealthy obesity. Ann Hepatol. 2020;19(4):359\u201366. https:\/\/doi.org\/10.1016\/j.aohep.2020.03.001.","journal-title":"Ann Hepatol"},{"issue":"1","key":"1483_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33. https:\/\/doi.org\/10.1186\/1471-230X-6-33.","journal-title":"BMC Gastroenterol"},{"key":"1483_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","volume":"75","author":"YC Zhao","year":"2020","unstructured":"Zhao YC, Zhao GJ, Chen Z, She ZG, Cai J, Li H. Nonalcoholic fatty liver disease: an emerging driver of hypertension. Hypertension. 2020;75:275\u201384.","journal-title":"Hypertension"},{"key":"1483_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fpubh.2020.00220","volume":"8","author":"X Pan","year":"2020","unstructured":"Pan X, Xie X, Peng H, Cai X, Li H, Hong Q, et al. Risk prediction for non-alcoholic fatty liver disease based on biochemical and dietary variables in a Chinese Han population. Front Public Health. 2020;8:220. https:\/\/doi.org\/10.3389\/fpubh.2020.00220.","journal-title":"Front Public Health"},{"issue":"3","key":"1483_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jped.2017.06.012","volume":"94","author":"CA Nogueira-de-Almeida","year":"2018","unstructured":"Nogueira-de-Almeida CA, Mello ED. Correlation of body mass index Z-scores with glucose and lipid profiles among overweight and obese ch ildren and adolescents. J Pediatr. 2018;94(3):308\u201312. https:\/\/doi.org\/10.1016\/j.jped.2017.06.012.","journal-title":"J Pediatr"},{"issue":"2","key":"1483_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1515\/jpem-2019-0369","volume":"33","author":"RAS Dejavitte","year":"2020","unstructured":"Dejavitte RAS, Enes CC, Nucci LB. Prevalence of metabolic syndrome and its associated factors in overweight and obese adolescents. J Pediatr Endocrinol Metab. 2020;33(2):233\u20139. https:\/\/doi.org\/10.1515\/jpem-2019-0369.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"1483_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41430-019-0539-1","volume":"74","author":"SAE Kauffman","year":"2020","unstructured":"Kauffman SAE, Averill MM, Delaney JAC, Lemaitre RN, Howard BV, Fretts AM. Associations of diet quality and blood serum lipoprotein levels in a population at high risk for diab etes: the strong heart family study. Eur J Clin Nutr. 2020;74(7):1084\u201390. https:\/\/doi.org\/10.1038\/s41430-019-0539-1.","journal-title":"Eur J Clin Nutr"},{"key":"1483_CR35","doi-asserted-by":"crossref","first-page":"e013713","DOI":"10.1161\/JAHA.119.013713","volume":"8","author":"JA Lamprea-Montealegre","year":"2019","unstructured":"Lamprea-Montealegre JA, McClelland RL, Otvos JD, Mora S, Koch M, Jensen MK, et al. Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III C ontent with cardiovascular disease risk according to kidney function: the multi-ethnic study of Athe rosclerosis. J Am Heart Assoc. 2019;8:e013713.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"1483_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","volume":"114","author":"TF L\u00fcscher","year":"2014","unstructured":"L\u00fcscher TF, Landmesser U, von Eckardstein A, Fogelman AM. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res. 2014;114(1):171\u201382. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.300935.","journal-title":"Circ Res"},{"issue":"3","key":"1483_CR37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/s0004-2803.201900000-51","volume":"56","author":"G Ray","year":"2019","unstructured":"Ray G, Agarwala T. A study of metabolic parameters in non diabetic patients with non alcoholic fatty liver disease - importance of Dyslipidemia. Arq Gastroenterol. 2019;56(3):270\u20135. https:\/\/doi.org\/10.1590\/s0004-2803.201900000-51.","journal-title":"Arq Gastroenterol"},{"issue":"4","key":"1483_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.4103\/2230-8210.113758","volume":"17","author":"R Kumar","year":"2013","unstructured":"Kumar R, Rastogi A, Sharma MK, Bhatia V, Garg H, Bihari C, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fat ty liver disease? Indian J Endocrinol Metab. 2013;17(4):665\u201371. https:\/\/doi.org\/10.4103\/2230-8210.113758.","journal-title":"Indian J Endocrinol Metab"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01483-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01483-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01483-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T14:14:46Z","timestamp":1672236886000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01483-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,25]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01483-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,25]]},"assertion":[{"value":"15 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the principles of the Declaration of Helsinki, the protocol was approved by the ethics committee of Hebei General Hospital, and all the participants gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}